Flucistad

Rx

Indications:

Indicated either alone or in combination with systemic therapy, in the treatment of skin infections caused by sensitive strains of Staphylococcus aureus, Streptococcus spp. and Corynebacterium minutissimum such as:

• Primary skin infections: Impetigo contagiosa, superficial folliculitis, sycosis barbae, paronchia and erythrasma.
• Secondary skin infections: Infected eczematoid dermatitis, infected contact dermatitis and infected cuts/ abrasions.

Dosage:

• Uncovered lesions: Apply gently three or four times daily.
• Covered lesions: Less frequent applications may be adequate.

Usage:

Flucistad is for topical use.

Known hypersensitivity to fusidic acid or to any of the excipients. Infection caused by non-susceptible organisms, in particular, Pseudomonas aeruginosa.

• Uncommon: Pruritus, rash (erythematous, macula-papular and pustular reactions), irritation at site of application (pain, stinging, burning and erythema).
• Rare: Hypersensitivity, conjunctivitis.
• Not known: Urticaria, angioedema, eczema, periorbital oedema.

• Use with caution in patients with hepatic or renal injury, glucose-6-phosphate dehydrogenase deficiency.
• Should only be used short term because of the risks of including bacterial resistance and contact allergy.
• Caution should be exercised when this drug is used in or near the eyes.
• Application of topical antibacterial to extensive areas of damaged skin can result in systemic toxicity.
• The use of topical fusidic acid in pregnancy requires that the potential benefits be weighed against the possible hazards to the fetus. This drug can be used in nursing woman. If used on the nipples, any cream on the nipples should be cleaned off before breast-feeding.